New Zealand markets closed

U.S. Physical Therapy, Inc. (USPH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
106.39+1.36 (+1.29%)
At close: 04:00PM EDT
106.39 0.00 (0.00%)
After hours: 06:11PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.58B
Enterprise value 1.71B
Trailing P/E 90.54
Forward P/E 40.82
PEG ratio (5-yr expected) 6.94
Price/sales (ttm)2.52
Price/book (mrq)3.30
Enterprise value/revenue 2.79
Enterprise value/EBITDA 22.92

Trading information

Stock price history

Beta (5Y monthly) 1.39
52-week change 3-5.22%
S&P500 52-week change 326.43%
52-week high 3124.11
52-week low 378.08
50-day moving average 3105.16
200-day moving average 397.45

Share statistics

Avg vol (3-month) 373.32k
Avg vol (10-day) 362.46k
Shares outstanding 515.07M
Implied shares outstanding 615.07M
Float 814.81M
% held by insiders 11.66%
% held by institutions 1105.61%
Shares short (15 Apr 2024) 4619.71k
Short ratio (15 Apr 2024) 48.13
Short % of float (15 Apr 2024) 45.52%
Short % of shares outstanding (15 Apr 2024) 44.11%
Shares short (prior month 15 Mar 2024) 4745.89k

Dividends & splits

Forward annual dividend rate 41.76
Forward annual dividend yield 41.65%
Trailing annual dividend rate 31.73
Trailing annual dividend yield 31.65%
5-year average dividend yield 41.27
Payout ratio 4149.14%
Dividend date 305 Apr 2024
Ex-dividend date 422 May 2024
Last split factor 23:2
Last split date 329 Jun 2001

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 4.77%
Operating margin (ttm)9.29%

Management effectiveness

Return on assets (ttm)4.43%
Return on equity (ttm)6.47%

Income statement

Revenue (ttm)605.68M
Revenue per share (ttm)41.24
Quarterly revenue growth (yoy)4.80%
Gross profit (ttm)N/A
EBITDA 82.88M
Net income avi to common (ttm)17.62M
Diluted EPS (ttm)1.16
Quarterly earnings growth (yoy)8.60%

Balance sheet

Total cash (mrq)132.29M
Total cash per share (mrq)8.78
Total debt (mrq)256.35M
Total debt/equity (mrq)38.15%
Current ratio (mrq)2.16
Book value per share (mrq)31.84

Cash flow statement

Operating cash flow (ttm)75.05M
Levered free cash flow (ttm)54.01M